ANDA 73667, held by Teva. Nortriptyline Hydrochloride.
As of Nov 15, 2026, ANDA 73667 (Nortriptyline Hydrochloride), held by Teva, was first approved by FDA on Apr 11, 1996, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 1996 | Original application | Approved | None posted |
| Nortriptyline HydrochlorideEQ 10MG BASE · capsule;oral | Nortriptyline Hydrochloride | Discontinued |
| Nortriptyline HydrochlorideEQ 25MG BASE · capsule;oral | Nortriptyline Hydrochloride | Discontinued |
| Nortriptyline HydrochlorideEQ 50MG BASE · capsule;oral | Nortriptyline Hydrochloride | Discontinued |
| Nortriptyline HydrochlorideEQ 75MG BASE · capsule;oral | Nortriptyline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
